Kalata B1

General Information


DRACP ID  DRACP00296

Peptide Name   Kalata B1

Sequence  GLPVCGETCVGGTCNTPGCTCSWPVCTRN

Sequence Length  29

UniProt ID  Not available

PubChem CID  Not available

Origin  Oldenlandia affinis; Viola yedoensis; Viola odorata; Viola baoshanensis

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MM96L Melanoma Carcinoma IC50=3.10±0.06µM MTT assay 5h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=10.21±0.43µM MTT assay 5h 1
BGC-823 Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=1.32±0.15µM SRB assay 48h 1
U-937/GTB Adult acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia IC50=6.9µM FMCA assay 72h 2
K562 Blast phase chronic myelogenous leukemia, BCR-ABL2 positive; Chronic myeloid leukemia Leukemia 50% Cell death=13.1±0.4µM Resazurin assay 2, 24h 3

Hemolytic Activity  Human erythrocytes: Human erythrocytes: 41% Hemolysis=25 µM; Human erythrocytes: 50% Hemolysis=29.1±1.1 µM

Normal (non-cancerous) Cytotoxicity  HFF-1: IC50=2.38±0.09 µM; 50% Cell death=12.0±0.5 µM; CEM-SS cells: IC50=5.7 µM; Human PBMC: 50% Cell death=11.2±0.5 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00296

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys5<--->Cys19; Cys9<--->Cys21; Cys14<--->Cys26; NCB: Gly1<--->Asn29

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C117H187N35O40S6

Absent amino acids  ADFHIKMQY

Common amino acids  C

Mass  341596

Pl  5.94

Basic residues  1

Acidic residues  1

Hydrophobic residues  5

Net charge  0

Boman Index  -1951

Hydrophobicity  15.17

Aliphatic Index  43.45

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5875

Absorbance 280nm  209.82

Polar residues  19

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21723349

Title  Isolation and characterization of cytotoxic cyclotides from Viola philippica

Doi 10.1016/j.peptides.2011.06.016

Year  2011

Literature 2

Pubmed ID 28669767

Title  Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra

Doi 10.1016/j.bbamem.2017.06.018

Year  2017

Literature 3

Pubmed ID 25099014

Title  Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting

Doi 10.1002/cbic.201402144

Year  2014

Literature 4

Pubmed ID 21576247

Title  Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities

Doi 10.1074/jbc.M111.253393

Year  2011

Literature 5

Pubmed ID 18081258

Title  Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis

Doi 10.1021/np070393g

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.